The higher prevalence of missense mutations in hemophilia B compared to hemophilia A could be important in determining a milder clinical phenotype in patients with severe hemophilia B

Eitemau Tebyg

• A contribution to the debate about the possible different clinical severity between hemophilia A and B
  gan: Melchiorre, Daniela, et al.
  Cyhoeddwyd: (2016)
• Why should hemophilia B be milder than hemophilia A?
  gan: Shetty, Shrimati, et al.
  Cyhoeddwyd: (2016)
• Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A
  gan: Melchiorre, Daniela, et al.
  Cyhoeddwyd: (2016)
• Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
  gan: Linari, Silvia, et al.
  Cyhoeddwyd: (2020)
• Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
  gan: Castaman, Giancarlo, et al.
  Cyhoeddwyd: (2016)